Related Experiment Videos
Proteomics for studying cancer cells and the development of chemoresistance
1Medizinische Klinik III, Hämatologie, Onkologie und Transfusionsmedizin, Universitätsklinikum Benjamin Franklin, Berlin, Germany.
Abstract:
Extensive studies during the last decades have identified several mechanisms through which cells escape the cytotoxic effects of a variety of chemotherapeutic drugs. One type of drug resistance is called multidrug resistance (MDR), because selection with one anticancer drug leads to cross-resistance with a wide range of other drugs. These MDR cells express frequently plasma transport proteins like p-glycoprotein. But cellular resistance to chemotherapy is multifactorial and may be affected by the cell cycle stage and proliferation status, biochemical mechanisms such as detoxification, cellular drug transport, or DNA replication and repair mechanisms. Several laboratory techniques, such as polymerase chain reaction, immunocytochemistry, flow cytometry, blotting, and fluorescent microscopy have been used for the identification of MDR markers and mechanisms. We review the possibilities in studying cancer biology and development of chemoresistance in cancer treatment using the proteomic approach.
Insights
Cells can resist chemotherapy through multidrug resistance (MDR), involving mechanisms like drug transport proteins. This review explores using proteomics to study cancer biology and chemoresistance development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cells develop resistance to chemotherapy through various mechanisms.
- Multidrug resistance (MDR) is a key challenge, where resistance to one drug confers resistance to others.
- MDR is often mediated by plasma transport proteins like p-glycoprotein and influenced by cellular factors.
Purpose of the Study:
- To review the mechanisms of cellular resistance to chemotherapy.
- To explore the potential of proteomics in studying cancer biology and chemoresistance.
- To highlight the role of MDR and its associated markers.
Main Methods:
- Review of existing literature on cellular drug resistance mechanisms.
- Discussion of laboratory techniques for identifying MDR markers (PCR, flow cytometry, etc.).
- Focus on the application of proteomic approaches in cancer research.
Main Results:
- Chemoresistance is multifactorial, involving drug transport, detoxification, DNA repair, and cell cycle status.
- Proteomics offers a comprehensive approach to identify and understand MDR mechanisms.
- Proteomic analysis can reveal novel biomarkers and therapeutic targets.
Conclusions:
- Understanding chemoresistance mechanisms is crucial for effective cancer treatment.
- Proteomics provides powerful tools to investigate complex cancer biology and drug resistance.
- Further research using proteomic approaches can advance the development of strategies to overcome chemoresistance.